CompletedNCT03542760
Acquired Methemoglobinemia Observational Registry
Studying Acquired methemoglobinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hospital Quality Foundation
- Principal Investigator
- Charles V Pollack, MD, MDHospital Quality Foundation
- Intervention
- Methylene Blue(drug)
- Enrollment
- 24 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2021
Study locations (30)
- Cedars Sinai, Los Angeles, California, United States
- UC Davis Health, Sacramento, California, United States
- Bridgeport Hospital, Bridgeport, Connecticut, United States
- Hartford Hospital, Hartford, Connecticut, United States
- Palmetto General, Palm Beach Gardens, Florida, United States
- Tampa General, Tampa, Florida, United States
- IU Health, Indianapolis, Indiana, United States
- University of Iowa, Iowa City, Iowa, United States
- University of Kansas Health System, Kansas City, Kansas, United States
- University of Maryland, Baltimore, Maryland, United States
- Partners Healthcare; Brigham and Women's, Boston, Massachusetts, United States
- UMass Memorial Medical Center, Worcester, Massachusetts, United States
- Henry Ford Health System, Detroit, Michigan, United States
- St John Medical Center, Detroit, Michigan, United States
- HealthPartners Regions, Saint Paul, Minnesota, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
Prove pharm
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03542760 on ClinicalTrials.gov